- Home
- Labeler Index
- Seqirus Pty Ltd.
- 33332-024
- NDC Crossover: 33332-024 Afluria
NDC Crossover 33332-024 Afluria
View and Compare Similar Products, Alternatives & Options
NDC Crossover of Similar Products Matching
The Similar Products in this help users find alternative medications and related products based on key similarities in their regulatory status, product name, active ingredients, dosage form, and administration route.
Explore similar products to 33332-024 – Afluria, . This list includes other cross-matching products that share:
- The same product name: Afluria
- OR Generic name:
- AND the same Administration Route:
- OR Dosage Form:
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Product Type |
|---|---|---|---|---|---|---|
| 19515-904 | Flulaval 2025/2026 | Influenza Virus Vaccine | Suspension | Intramuscular | Id Biomedical Corporation Of Quebec | Vaccine |
| 33332-025 | Afluria | Influenza A Virus A/victoria/4897/2022 Ivr-238 (h1n1) Antigen (propiolactone Inactivated), Influenza A Virus A/croatia/10136rv/2023 X-425a (h3n2) Antigen (propiolactone Inactivated), Influenza B Virus B/austria/1359417/2021 Bvr-26 Antigen (propiolactone Inactivated) | Injection, Suspension | Intramuscular | Seqirus Pty Ltd. | Vaccine |
| 33332-125 | Afluria | Influenza A Virus A/victoria/4897/2022 Ivr-238 (h1n1) Antigen (propiolactone Inactivated), Influenza A Virus A/croatia/10136rv/2023 X-425a (h3n2) Antigen (propiolactone Inactivated), Influenza B Virus B/austria/1359417/2021 Bvr-26 Antigen (propiolactone Inactivated) | Injection, Suspension | Intramuscular | Seqirus Pty Ltd. | Vaccine |
| 70461-025 | Fluad | Influenza A Virus A/victoria/4897/2022 Ivr-238 (h1n1) Antigen (formaldehyde Inactivated), Influenza A Virus A/croatia/10136rv/2023 X-425a (h3n2) Antigen (formaldehyde Inactivated), Influenza B Virus B/austria/1359417/2021 Bvr-26 Antigen (formaldehyde Inactivated) | Injection, Suspension | Intramuscular | Seqirus, Inc. | Vaccine |
